Xtant Medical Holdings (XTNT) Non-Current Assets (2010 - 2025)
Xtant Medical Holdings' (XTNT) quarterly Non-Current Assets came in at $15.9 million in Q4 2025, down 40.5% year-on-year from $26.7 million in Q4 2024, and down 43.2% on a QoQ basis from $28.0 million in Q3 2025.
Xtant Medical Holdings (XTNT) Non-Current Assets (2010 - 2025) Analysis & Trends
Xtant Medical Holdings (XTNT) has 16 years of Non-Current Assets data on file, last reported at $15.9 million in Q4 2025.
- On a quarterly basis, Non-Current Assets fell 40.5% year-over-year to $15.9 million in Q4 2025; TTM through Dec 2025 was $98.5 million, a 8.98% decrease from a year earlier, with the FY2025 full-year figure at $15.9 million, down 40.5% from the prior year.
- Non-Current Assets for Q4 2025 stood at $15.9 million, down from $28.0 million in the prior quarter.
- Over the last five years, Non-Current Assets for XTNT reached as high as $28.0 million in Q3 2025 and fell as low as $10.2 million in Q3 2021.
- Historically, Non-Current Assets has averaged $19.9 million across 5 years, with a median of $26.1 million in 2023.
- Across the five-year window, Non-Current Assets jumped 156.76% in 2023 and tumbled 40.5% in 2025, its largest moves.
- Year by year, Non-Current Assets stood at $10.4 million in 2021, then grew by 5.3% to $10.9 million in 2022, then jumped by 154.27% to $27.7 million in 2023, then slipped by 3.68% to $26.7 million in 2024, then tumbled by 40.5% to $15.9 million in 2025.
- Per Business Quant data, the three most recent Non-Current Assets figures were $15.9 million in Q4 2025, $28.0 million in Q3 2025, and $27.9 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.30 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 20.47 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 6.35 Bn |
| 10 | Xtant Medical Holdings | 5.69 Mn | -11.63 Mn | 17.75 Mn | 15.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 15.90 Mn |
| Sep 30, 2025 | 27.99 Mn |
| Jun 30, 2025 | 27.89 Mn |
| Mar 31, 2025 | 26.69 Mn |
| Dec 31, 2024 | 26.72 Mn |
| Sep 30, 2024 | 27.47 Mn |
| Jun 30, 2024 | 26.61 Mn |
| Mar 31, 2024 | 27.39 Mn |
| Dec 31, 2023 | 27.74 Mn |
| Sep 30, 2023 | 27.90 Mn |
| Jun 30, 2023 | 25.65 Mn |
| Mar 31, 2023 | 26.73 Mn |
| Dec 31, 2022 | 10.91 Mn |
| Sep 30, 2022 | 10.94 Mn |
| Jun 30, 2022 | 10.38 Mn |
| Mar 31, 2022 | 10.41 Mn |
| Dec 31, 2021 | 10.36 Mn |
| Sep 30, 2021 | 10.20 Mn |
| Jun 30, 2021 | 10.24 Mn |
| Mar 31, 2021 | 10.22 Mn |